abstract |
The present invention relates to an inhibitor of ataxia-telangiecstasia and Rad3-related protein (ATR), which is a compound of formula (Ia) or a pharmaceutically acceptable salt thereof, including compounds used for the indicated purpose, as well as to liposomal compositions containing an ATR protein kinase inhibitor. These compositions are suitable for the treatment of cancer. |